Perfromance Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Sell |
28,299
-4,112
| -13% | -$284K | 0.06% | 51 |
|
|
2025
Q1 | $2.25M | Buy |
32,411
+458
| +1% | +$31.8K | 0.08% | 44 |
|
|
2024
Q4 | $2.75M | Sell |
31,953
-127,184
| -80% | -$10.9M | 0.09% | 36 |
|
|
2024
Q3 | $18.9M | Buy |
159,137
+8,419
| +6% | +$1M | 0.65% | 18 |
|
|
2024
Q2 | $21.5M | Buy |
150,718
+87,047
| +137% | +$12.4M | 0.79% | 17 |
|
|
2024
Q1 | $8.18M | Buy |
63,671
+13,074
| +26% | +$1.68M | 0.34% | 23 |
|
|
2023
Q4 | $5.23M | Buy |
50,597
+9,961
| +25% | +$1.03M | 0.23% | 34 |
|
|
2023
Q3 | $3.7M | Buy |
40,636
+374
| +0.9% | +$34K | 0.18% | 48 |
|
|
2023
Q2 | $3.22M | Buy |
40,262
+2,600
| +7% | +$208K | 0.15% | 49 |
|
|
2023
Q1 | $3M | Buy |
37,662
+200
| +0.5% | +$15.9K | 0.15% | 49 |
|
|
2022
Q4 | $2.54M | Buy |
37,462
+2,562
| +7% | +$173K | 0.15% | 48 |
|
|
2022
Q3 | $1.74M | Buy |
34,900
+3,200
| +10% | +$159K | 0.1% | 50 |
|
|
2022
Q2 | $1.77M | Buy |
31,700
+1,684
| +6% | +$93.8K | 0.1% | 52 |
|
|
2022
Q1 | $1.67M | Buy |
30,016
+2,498
| +9% | +$139K | 0.07% | 58 |
|
|
2021
Q4 | $1.54M | Buy |
+27,518
| New | +$1.54M | 0.06% | 65 |
|